Explore

Communities in English

Advertise on Engormix

Controversial racehorse drug to be studied

Published: October 17, 2007
Summary
Debate about horseracing drug may be solved with C olorado State University and partner research in S outh Africa. A study led by Colorado State University and research partners will help to answer a long-debated question about health and performance effects of a drug commonly used to treat racehorses in the U.S. to prevent bleeding into their airways as they run. The study, which ...
Related topics:
Recommend
Comment
Share
heaton  david
heaton david
17 de octubre de 2007

Would this drug have the same effect on horse racing drug?

 

 

Recommend
Reply
Maria Costa
Maria Costa
18 de octubre de 2007

I am sorry but you are wrong to say that Furosemide is banned on all other countries appart from the US and Canada.
Brazil also allows their Thoroughbreds to use Furosemide on raceday as a potential reducer of EIPH.

Recommend
Reply
Martin Eduardo Lucione
22 de abril de 2009
Ref: Controversial racehorse drug sees studied The effects of the furosemide one in horses with cases out of pulmonary hemorrhage induced by exercise, plows contradictory in relation to their beneficial effects in horses with that pathology. In Argentina and EE.UU. to near 80% of the horses they run with doses that oscillate between (2ml and 6 total milliliter). According to some studies the furosemide: One: Would reduces the blood pressure Two: Would produce severe electrolytic lost According to studies the electrolytic supplementation would see beneficial to counteract those effects.
Recommend
Reply
1
Profile picture
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Featured users in Equine
Tania Cubitt
Tania Cubitt
Virginia Tech
Virginia Tech
United States
Tiffany Lea Fisher
Tiffany Lea Fisher
Tiffany Lea
United States
Samuel Lainez
Samuel Lainez
Meta Data Life Sciences
United States
Join Engormix and be part of the largest agribusiness social network in the world.